Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Alembic Pharmaceuticals Ltd. is a renowned entity in the global pharmaceutical market, focusing on the development, manufacture, and commercialization of pharmaceutical products. Based in India, the company produces a diverse range of active pharmaceutical ingredients (APIs) and formulations for both the domestic and international markets. Alembic Pharmaceuticals is noted for its extensive portfolio in the therapeutic areas of anti-infective, anti-diabetic, cardiovascular, gastrointestinal, and central nervous system medicines. The company's commitment to research and development is evident through its state-of-the-art facilities and a robust pipeline of new products. With a presence in more than 75 countries, Alembic Pharmaceuticals plays a significant role in delivering affordable and quality healthcare solutions. Its operations impact multiple sectors, including healthcare providers, pharmacies, and governmental healthcare systems, underlining its crucial position in the pharmaceutical supply chain. The company continues to expand its global footprint through strategic partnerships and international trade, contributing to the advancement of medical treatment and overall public health on a significant scale.
Select a linked metric to explore its chart.